Soluble CD137 and risk of hepatocellular carcinoma: nested case–control studies in cohorts in Shanghai and Singapore
Year: 2023
Type: article
Study design: Observational Study
Source: British Journal of Cancer
Institutions: University of Pittsburgh, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, National University of Singapore, Agency for Science, Technology and Research, Singapore Institute for Clinical Sciences, Shanghai Jiao Tong University, Renji Hospital, Shanghai Cancer Institute, UPMC Health System
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1015314651, Cancer Center Support Grant, Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes, THE SINGAPORE COHORT STUDY OF DIET AND CANCER, G335053239, DIETARY FACTORS IN THE ETIOLOGY OF CANCER IN SHANGHAI, G4147487232, G6921769403, Cancer epidemiology cohorts in Shanghai and Singapore , G741073515, G743835219, G8105098291, The Singapore Chinese Health Study, G8514092614, G8686599385, G8915614848, G9000010196, G9000197668, G9000304508, Translational Research Training in Cancer Prevention and Control, Prospective studies of cancer etiology and prevention in Shanghai and Singapore
OpenAlex ID: W4361204526
